Growth Metrics

Boston Scientific (BSX) Non-Current Debt (2016 - 2026)

Boston Scientific's Non-Current Debt history spans 18 years, with the latest figure at $11.0 billion for Q1 2026.

  • On a quarterly basis, Non-Current Debt rose 4.33% to $11.0 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $11.0 billion, a 4.33% increase, with the full-year FY2025 number at $11.1 billion, up 24.19% from a year prior.
  • Non-Current Debt hit $11.0 billion in Q1 2026 for Boston Scientific, down from $11.1 billion in the prior quarter.
  • Over the last five years, Non-Current Debt for BSX hit a ceiling of $11.1 billion in Q4 2025 and a floor of $8.4 billion in Q3 2023.
  • Historically, Non-Current Debt has averaged $9.5 billion across 5 years, with a median of $9.0 billion in 2024.
  • Biggest five-year swings in Non-Current Debt: decreased 6.31% in 2023 and later rose 24.19% in 2025.
  • Tracing BSX's Non-Current Debt over 5 years: stood at $8.9 billion in 2022, then decreased by 3.86% to $8.6 billion in 2023, then increased by 4.63% to $9.0 billion in 2024, then increased by 24.19% to $11.1 billion in 2025, then dropped by 1.34% to $11.0 billion in 2026.
  • Business Quant data shows Non-Current Debt for BSX at $11.0 billion in Q1 2026, $11.1 billion in Q4 2025, and $11.1 billion in Q3 2025.